- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04013594
Effect of Preoperative Oral Carbohydrates on the Glycemic Variability of Diabetic Patients
May 23, 2021 updated by: Yonsei University
Preoperative carbohydrate drink intake attenuate insulin resistance.
However, carbohydrate loading may compromise blood glucose control in patients with diabetes.
There is some evidence that oral carbohydrate loading may be safe in patients with type 2 diabetes.
Therefore, the investigators aim to evaluate whether preoperative carbohydrate intake affects insulin resistance and glycemic variability in patients with diabetes.
Fifty patients scheduled for total knee arthroplasty will be divided into carbohydrate (n=25) and control (n=25) groups.
Randomly selected patients of the carbohydrate group are given 400ml of 12.8 g/100 ml carbohydrate beverage 2-3 hours before their scheduled operation.
In contrast, patients in the control group are fasted from water 2 hours before surgery according to standard protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 1. Patients undergoing total knee arthroplasty
Exclusion Criteria:
- 1. Patients with contraindications to spinal anesthesia (local infection, clotting disorders, anatomical abnormalities, sepsis, etc.)
- 2. Patients with gastroesophageal reflux disease, gastric emptying disorders, inflammatory bowel disease, or previous treatment for intra-abdominal cancer
- 3. Patients with chronic renal disease or severe cardiovascular disease
- 4. HbA1c >69 mmol/mol or BMI >30 kg/m2
- 5. A duration of ≥5 hours between consumption of CHO and initiation of surgery.
- 6. The subject is a foreigner or illiterate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: control group
|
|
EXPERIMENTAL: carbohydrate group(CHO group)
|
Randomly selected patients of the carbohydrate group are given oral carbohydrate (400ml) 2-3 hours before surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic variability
Time Frame: Before anesthesia
|
- Coefficient of glucose variability =SD/mean x 100 (%)
|
Before anesthesia
|
Glycemic variability
Time Frame: Before anesthesia
|
- J index=0.001 x (MBG +SD)2 mg/dL
|
Before anesthesia
|
Glycemic variability
Time Frame: immediately after anesthesia
|
- Coefficient of glucose variability =SD/mean x 100 (%)
|
immediately after anesthesia
|
Glycemic variability
Time Frame: immediately after anesthesia
|
- J index=0.001 x (MBG +SD)2 mg/dL
|
immediately after anesthesia
|
Glycemic variability
Time Frame: operation end
|
- Coefficient of glucose variability =SD/mean x 100 (%)
|
operation end
|
Glycemic variability
Time Frame: operation end
|
- J index=0.001 x (MBG +SD)2 mg/dL
|
operation end
|
Glycemic variability
Time Frame: 1 hour after surgery
|
- Coefficient of glucose variability =SD/mean x 100 (%)
|
1 hour after surgery
|
Glycemic variability
Time Frame: 1 hour after surgery
|
- J index=0.001 x (MBG +SD)2 mg/dL
|
1 hour after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulin resistance
Time Frame: Before anesthesia
|
Insulin resistance index = fasting glucose x fasting insulin/22.5
|
Before anesthesia
|
Insulin resistance
Time Frame: Before anesthesia
|
serum laboratory test: glucagon
|
Before anesthesia
|
Insulin resistance
Time Frame: Before anesthesia
|
serum laboratory test: GLP-1
|
Before anesthesia
|
Insulin resistance
Time Frame: Before anesthesia
|
serum laboratory test: C-peptide
|
Before anesthesia
|
Insulin resistance
Time Frame: Before anesthesia
|
serum laboratory test: free fatty acid
|
Before anesthesia
|
gastric volume
Time Frame: Before anesthesia
|
gastric volume measured by ultrasonography.
|
Before anesthesia
|
hand grip strength
Time Frame: Before anesthesia
|
hand grip strength measured by electronic hand dynamometer
|
Before anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab. 2001 Apr;280(4):E576-83. doi: 10.1152/ajpendo.2001.280.4.E576.
- Gustafsson UO, Nygren J, Thorell A, Soop M, Hellstrom PM, Ljungqvist O, Hagstrom-Toft E. Pre-operative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand. 2008 Aug;52(7):946-51. doi: 10.1111/j.1399-6576.2008.01599.x. Epub 2008 Mar 7.
- Lee B, Kim SY, Cho BW, Suh S, Park KK, Choi YS. Preoperative Carbohydrate Drink Intake Increases Glycemic Variability in Patients with Type 2 Diabetes Mellitus in Total Joint Arthroplasty: A Prospective Randomized Trial. World J Surg. 2022 Apr;46(4):791-799. doi: 10.1007/s00268-021-06437-1. Epub 2022 Jan 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 20, 2019
Primary Completion (ACTUAL)
October 7, 2020
Study Completion (ACTUAL)
October 15, 2020
Study Registration Dates
First Submitted
June 26, 2019
First Submitted That Met QC Criteria
July 3, 2019
First Posted (ACTUAL)
July 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 25, 2021
Last Update Submitted That Met QC Criteria
May 23, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 4-2019-0428
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on carbohydrate group
-
Mingkwan Wongyingsinn, MDCompletedColorectal Neoplasms | Difficulty Walking | Bowel; Disease, Carbohydrate AbsorptionThailand
-
Karaman Training and Research HospitalRecruiting
-
University of ThessalyUniversity of Nicosia; University of CyprusCompletedFatigue | Sleepiness | Feeding Patterns | Daytime Sleepiness, ExcessiveGreece, Cyprus
-
Yonsei UniversityCompletedOld AgeKorea, Republic of
-
Third Affiliated Hospital of Zhengzhou UniversityNot yet recruitingObesity | Weight Loss | Male Fertility | IVF-ET | Artificial Insemination
-
Yonsei UniversityUnknown
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Metabolic Syndrome | DyslipidemiasUnited States
-
Unilever R&DCompleted
-
University of Illinois at Urbana-ChampaignAbbott NutritionCompletedDietary Modification | Cognitive Ability, GeneralUnited States
-
Seoul National University Bundang HospitalCompletedFastingKorea, Republic of